Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial
Kamaria L. Lee, Clinton Yam, Li Zhao, Roland L. Bassett, Xingzhi Song, Alastair M. Thompson, Jason B. White, Rachel M. Layman, Lei Huo, Angelica M. Gutierrez, Vicente Valero, Naoto T. Ueno, Jennifer K. Litton, Jianhua Zhang, Elizabeth Ravenberg, Anil Korkut, Beatriz E. Adrada, Rosalind P. Candelaria, Gaiane M. Rauch, Debu Tripathy, Simona F. Shaitelman, Banu K. Arun
Springer Nature ·
2026-06-01
· DOI 10.1007/s10549-026-07985-7
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Kamaria L. Lee, Clinton Yam, Li Zhao, Roland L. Bassett, Xingzhi Song, Alastair M. Thompson et al. Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial. // Breast Cancer Research and Treatment. – 2026. – DOI: 10.1007/s10549-026-07985-7. – URL: https://doi.org/10.1007/s10549-026-07985-7
Kamaria L. Lee, Clinton Yam, Li Zhao, Roland L. Bassett, Xingzhi Song, Alastair M. Thompson, Jason B. White, Rachel M. Layman, Lei Huo, Angelica M. Gutierrez, Vicente Valero, Naoto T. Ueno, Jennifer K. Litton, Jianhua Zhang, Elizabeth Ravenberg, Anil Korkut, Beatriz E. Adrada, Rosalind P. Candelaria, Gaiane M. Rauch, Debu Tripathy, Simona F. Shaitelman, & Banu K. Arun (2026). Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-07985-7
Kamaria L. Lee, et al. “Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial.” Breast Cancer Research and Treatment, 2026. doi:10.1007/s10549-026-07985-7.
@article{Lee2026,
title = {Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial},
author = {Lee, Kamaria L. and Yam, Clinton and Zhao, Li and Bassett, Roland L. and Song, Xingzhi and Thompson, Alastair M. and White, Jason B. and Layman, Rachel M. and Huo, Lei and Gutierrez, Angelica M. and Valero, Vicente and Ueno, Naoto T. and Litton, Jennifer K. and Zhang, Jianhua and Ravenberg, Elizabeth and Korkut, Anil and Adrada, Beatriz E. and Candelaria, Rosalind P. and Rauch, Gaiane M. and Tripathy, Debu and Shaitelman, Simona F. and Arun, Banu K.},
journal = {Breast Cancer Research and Treatment},
year = {2026},
doi = {10.1007/s10549-026-07985-7},
url = {https://doi.org/10.1007/s10549-026-07985-7}
}